Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies.
about
Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Sofosbuvir-Based Direct-Acting ...... n Analysis of Phase 3 Studies.
@en
Sofosbuvir-Based Direct-Acting ...... n Analysis of Phase 3 Studies.
@nl
type
label
Sofosbuvir-Based Direct-Acting ...... n Analysis of Phase 3 Studies.
@en
Sofosbuvir-Based Direct-Acting ...... n Analysis of Phase 3 Studies.
@nl
prefLabel
Sofosbuvir-Based Direct-Acting ...... n Analysis of Phase 3 Studies.
@en
Sofosbuvir-Based Direct-Acting ...... n Analysis of Phase 3 Studies.
@nl
P2093
P2860
P50
P356
P1476
Sofosbuvir-Based Direct-Acting ...... n Analysis of Phase 3 Studies.
@en
P2093
Diana M Brainard
Graham Foster
Gregory J Dore
Heshaam M Mir
Ira Jacobson
Jason Grebely
Joe Llewellyn
John McNally
Jordan J Feld
P2860
P304
P356
10.1093/OFID/OFY001
P577
2018-02-09T00:00:00Z